Literature DB >> 32246624

MicroRNAs as disease progression biomarkers and therapeutic targets in experimental autoimmune encephalomyelitis model of multiple sclerosis.

Bridget Martinez1, Philip V Peplow2.   

Abstract

Multiple sclerosis is an autoimmune neurodegenerative disease of the central nervous system characterized by pronounced inflammatory infiltrates entering the brain, spinal cord and optic nerve leading to demyelination. Focal demyelination is associated with relapsing-remitting multiple sclerosis, while progressive forms of the disease show axonal degeneration and neuronal loss. The tests currently used in the clinical diagnosis and management of multiple sclerosis have limitations due to specificity and sensitivity. MicroRNAs (miRNAs) are dysregulated in many diseases and disorders including demyelinating and neuroinflammatory diseases. A review of recent studies with the experimental autoimmune encephalomyelitis animal model (mostly female mice 6-12 weeks of age) has confirmed miRNAs as biomarkers of experimental autoimmune encephalomyelitis disease and importantly at the pre-onset (asymptomatic) stage when assessed in blood plasma and urine exosomes, and spinal cord tissue. The expression of certain miRNAs was also dysregulated at the onset and peak of disease in blood plasma and urine exosomes, brain and spinal cord tissue, and at the post-peak (chronic) stage of experimental autoimmune encephalomyelitis disease in spinal cord tissue. Therapies using miRNA mimics or inhibitors were found to delay the induction and alleviate the severity of experimental autoimmune encephalomyelitis disease. Interestingly, experimental autoimmune encephalomyelitis disease severity was reduced by overexpression of miR-146a, miR-23b, miR-497, miR-26a, and miR-20b, or by suppression of miR-182, miR-181c, miR-223, miR-155, and miR-873. Further studies are warranted on determining more fully miRNA profiles in blood plasma and urine exosomes of experimental autoimmune encephalomyelitis animals since they could serve as biomarkers of asymptomatic multiple sclerosis and disease course. Additionally, studies should be performed with male mice of a similar age, and with aged male and female mice.

Entities:  

Keywords:  animal model; blood plasma; blood serum; brain tissue; disease biomarkers; experimental autoimmune encephalomyelitis; microRNAs; multiple sclerosis; spinal cord; therapeutic targets; urine exosomes

Year:  2020        PMID: 32246624     DOI: 10.4103/1673-5374.280307

Source DB:  PubMed          Journal:  Neural Regen Res        ISSN: 1673-5374            Impact factor:   5.135


  9 in total

1.  ISGylation is induced in neurons by demyelination driving ISG15-dependent microglial activation.

Authors:  Benjamin D S Clarkson; Ethan Grund; Kenneth David; Renee K Johnson; Charles L Howe
Journal:  J Neuroinflammation       Date:  2022-10-20       Impact factor: 9.587

2.  miR-150-5p and let-7b-5p in Blood Myeloid Extracellular Vesicles Track Cognitive Symptoms in Patients with Multiple Sclerosis.

Authors:  Federica Scaroni; Caterina Visconte; Maria Serpente; Maria Teresa Golia; Martina Gabrielli; Marijn Huiskamp; Hanneke E Hulst; Tiziana Carandini; Milena De Riz; Anna Pietroboni; Emanuela Rotondo; Elio Scarpini; Daniela Galimberti; Charlotte E Teunissen; Maureen van Dam; Brigit A de Jong; Chiara Fenoglio; Claudia Verderio
Journal:  Cells       Date:  2022-05-05       Impact factor: 7.666

Review 3.  Exosomes as a Promising Therapeutic Strategy for Peripheral Nerve Injury.

Authors:  Tianhao Yu; Yingxi Xu; Muhammad Arslan Ahmad; Rabia Javed; Haruo Hagiwara; Xiaohong Tian
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

4.  Bu Shen Yi Sui Capsule Alleviates Neuroinflammation and Demyelination by Promoting Microglia toward M2 Polarization, Which Correlates with Changes in miR-124 and miR-155 in Experimental Autoimmune Encephalomyelitis.

Authors:  Zheng Zha; Yan-Fang Gao; Jing Ji; Ya-Qin Sun; Jun-Ling Li; Fang Qi; Nan Zhang; Liang-Yun Jin; Bing Xue; Tao Yang; Yong-Ping Fan; Hui Zhao; Lei Wang
Journal:  Oxid Med Cell Longev       Date:  2021-03-16       Impact factor: 6.543

5.  Evaluation of the expressed miR-129 and miR-549a in patients with multiple sclerosis.

Authors:  Mina Montazeri; Nahid Eskandari; Reza Mansouri
Journal:  Adv Biomed Res       Date:  2021-12-25

Review 6.  Extracellular vesicles (exosomes and ectosomes) play key roles in the pathology of brain diseases.

Authors:  Jacopo Meldolesi
Journal:  Mol Biomed       Date:  2021-06-20

7.  Global MicroRNAs Expression Profile Analysis Reveals Possible Regulatory Mechanisms of Brain Injury Induced by Toxoplasma gondii Infection.

Authors:  Zhaofeng Hou; Lele Wang; Dingzeyang Su; Weimin Cai; Yu Zhu; Dandan Liu; Siyang Huang; Jinjun Xu; Zhiming Pan; Jianping Tao
Journal:  Front Neurosci       Date:  2022-03-10       Impact factor: 4.677

Review 8.  The Therapeutic Potential of Exosomes in Soft Tissue Repair and Regeneration.

Authors:  Rou Wan; Arif Hussain; Atta Behfar; Steven L Moran; Chunfeng Zhao
Journal:  Int J Mol Sci       Date:  2022-03-31       Impact factor: 5.923

9.  Oligodendrocyte-specific Argonaute profiling identifies microRNAs associated with experimental autoimmune encephalomyelitis.

Authors:  Qin Ma; Atsuko Matsunaga; Brenda Ho; Jorge R Oksenberg; Alessandro Didonna
Journal:  J Neuroinflammation       Date:  2020-10-12       Impact factor: 8.322

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.